BioSpace News Archive

Genetown

Stoke Therapeutics to Present on First Precision Treatments for Genetic Epilepsies at J.P. Morgan Healthcare Conference

Stoke Therapeutics will present on its pioneering work to develop the first gene-specific, disease-modifying therapies for genetic epilepsies at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco next week.

January 3, 2019
·
2 min read
Drug Development

Seres Therapeutics Announces Initiation of SER-287 Phase 2B ECO-RESET Clinical Study for Ulcerative Colitis

Recent FDA correspondence indicates this SER-287 Phase 2B study may support Biologics License Application (BLA)

January 3, 2019
·
5 min read
BioCapital

Viela Bio Announces Inebilizumab Achieved Primary and Key Secondary Endpoints in Pivotal Trial in Patients with Neuromyelitis Optica Spectrum Disorder (NMOSD)

Largest controlled monotherapy trial in NMOSD demonstrates reduction in risk of attacks and reduction in worsening of disability in patients treated with inebilizumab

January 3, 2019
·
4 min read
Business

Incyte Appoints Christiana Stamoulis as Chief Financial Officer

Incyte today announced the appointment of Christiana Stamoulis as Executive Vice President and Chief Financial Officer, effective February 11, 2019. Ms. Stamoulis will succeed David Gryska who, as planned, retired from Incyte at the end of 2018.

January 3, 2019
·
2 min read
Business

Molina Healthcare Renews Agreement with CVS Caremark for Pharmacy Benefit Management

Molina Healthcare, Inc. today announced that, following a comprehensive procurement process, it has extended its agreement with CVS Caremark for pharmacy benefit management (PBM) services through 2021.

January 3, 2019
·
2 min read
BioForest

Adaptive Biotechnologies to Present at the 37th Annual J.P. Morgan Healthcare Conference

Adaptive Biotechnologies today announced that Chad Robins, chief executive officer and co-founder, will present at the 37th Annual J.P. Morgan Healthcare Conference on January 8, 2019 at 11:30 am PT (2:30 pm ET) in San Francisco.

January 3, 2019
·
1 min read
Deals

TILT Holdings Agrees to Acquire Jupiter Research

Jupiter Research’s proprietary inhalation technology advances and diversifies TILT’s comprehensive portfolio of cannabis solutions across the supply chain

January 3, 2019
·
8 min read
Genetown

Frequency Therapeutics to Present at the 37th Annual JP Morgan Healthcare Conference

Frequency Therapeutics today announced that the Company will present at the upcoming 37th Annual JP Morgan Healthcare Conference in San Francisco on Monday, January 7, 2019

January 3, 2019
·
1 min read
BioMidwest

Kraig Biocraft Laboratories Completes Final Facilities Review for First Batch of Recombinant Spider Silk Production in Vietnam

Kraig Biocraft Laboratories, Inc. announces today that key members of its management and production team have laid the groundwork for the Company’s Vietnamese spider silk production initiative.

January 3, 2019
·
3 min read
Genetown

Verastem Oncology to Present at the 37th Annual J.P. Morgan Healthcare Conference

Verastem, Inc. today announced that the Company will present at the 37th Annual J.P. Morgan Healthcare Conference on Thursday, January 10, 2019 at 11:00 a.m. PST in San Francisco, CA.

January 3, 2019
·
1 min read